Purchase the ATMP report at www.evernowpublishing.com

Subscribe to MedNous and get ahead in the business of medical innovation. Subscribe now.

The latest MedNous journal. Subscribe to download.

UK diagnostics company gets funding

Country: United Kingdom

Abingdon Health Ltd, a UK-based diagnostic company, has obtained £3 million from a syndicate of investors led by Imperial Innovations Group Plc to support the commercialisation of its recently launched device to detect multiple myeloma.

Read more

DBV Technologies to raise new capital in US

Country: France

DBV Technologies SA, a French company which is developing a patch for peanut and milk allergies, has announced plans for a second US share offering in less than a year to support development of its technology.

Read more

Commentary - Cosmo spins out Cassiopea SpA

Country: Italy

Read more

Pieris offering expected to raise $22.7 million

Country: Germany

Read more

Medigene secures new capital

Country: Germany

Read more

Alzheimer’s trial fails to meet endpoint

Country: Germany

Read more

Celgene and Juno team up in cancer

Country: United States

Read more

Transgene restructures with loss of 120 jobs

Country: France

Read more

Eli Lilly and Immunocore to test combination therapy

Country: United Kingdom

Read more

Novartis acquires neurology company

Country: Switzerland

Read more

Allergy Therapeutics outlines plans for US trials

Country: United Kingdom

Read more

EMA recommends HDAC inhibitor for myeloma

Country: United Kingdom

Read more

Looking for more?

Visit our news section for more articles.

News
Our full Mednous news archive
Appointments
Latest industry appointments
Events
A list of upcoming industry events

About Mednous

MedNous is a print publication and a website for everyone involved in medical research in Europe.

Read more

Free Article

Oncurious - a paediatric oncology company, by Jérôme Van Biervliet

CommentaryVIBJérômeVanBiervlietJun2015.pdf

Highlights of the June 2015 MedNous issue

The June 2015 MedNous features:

Latest Mednous cover
  • Financial Strategy
    Identifying promising assets early
    Interview with Novo Seeds
  • Business Strategy
    Virtual drug development at Verona Pharma
  • Commentary
    Tackling paediatric cancer
    By Jérôme Van Biervliet
  • Commentary
    Patent filings for antibiotics lag
    by Jennifer Bailey
  • Commentary
    Achieving safe and timely access to new medicines
    By Johan Strômquist

The latest MedNous journal. Subscribe to download.